Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-59,900
Closed -$4.04M 1111
2025
Q3
$4.04M Buy
59,900
+20,000
+50% +$1.33M 0.84% 27
2025
Q2
$2.6M Buy
+39,900
New +$2.39M 0.5% 38
2019
Q2
Sell
-500
Closed -$2.42M 351
2019
Q1
$2.42M Buy
+500
New +$22.5K 0.44% 46

Other funds holding HOLX

Summit Securities Group's HOLX Position: Q2 2026 in Review

Summit Securities Group sold out of Hologic (HOLX) in Q2 2026, closing a stake of 36 shares — an estimated $2.72K sold.

Summit Securities Group first reported a position in HOLX in Q1 2022 and held it in 10 quarters. The position peaked at $93.4K in Q3 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Summit Securities Group reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Summit Securities Group sold 36 Hologic shares in Q2 2026, an estimated $2.72K.
  • Summit Securities Group first reported a position in Hologic in Q1 2022 and held it in 10 quarters.
  • Summit Securities Group's Hologic position peaked at $93.4K in Q3 2025.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.